Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 1/20 | 0.38 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | HTR3A | P46098 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL28756352 | 0.90 | EDNRA (0.36) | CFTRGOPCLMNACYP3A4MAPT | |
| SCHEMBL5967745 | 0.83 | MEN1 (0.34) | CFTRGOPCLMNAMAPTMAPK1 | |
| SCHEMBL6924825 | 0.81 | EGFR (0.37) | CYP1A2TP53CYP3A4HTR2BALDH1A1 | |
| SCHEMBL29008132 | 0.78 | HTR2A (0.34) | CFTRGOPCCYP3A4HTR2AALDH1A1 | |
| SCHEMBL7576497 | 0.76 | HDAC4 (0.33) | CFTRGOPCALDH1A1CYP19A1CYP11B1 | |
| SCHEMBL13414982 | 0.76 | CYP2A6 (0.39) | CYP1A2TP53MAPTMAPK1ALDH1A1 | |
| SCHEMBL3213322 | 0.75 | ADORA2A (0.36) | LMNACYP1A2ALDH1A1GAAHPGD | |
| SCHEMBL27448383 | 0.75 | ALDH1A1 (0.33) | CFTRGOPCALDH1A1CYP19A1CYP11B1 | |
| SCHEMBL6673270 | 0.73 | GAA (0.35) | LMNACYP1A2TP53CYP3A4MAPT | |
| SCHEMBL15661815 | 0.73 | HDAC4 (0.38) | LMNACYP1A2TP53CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2859069-B1 | METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT | FERRARA MARCELLO (IT) | 2020-10-14 | — | — | EP | claimed |
| US-9328300-B2 | Method, apparatus and chemical products for treating petroleum equipment | FERRARA MARCELLO (IT) | 2016-05-03 | — | — | US | claimed |
| EP-2859069-A1 | METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT | Ferrara, Marcello (IT) | 2015-04-15 | — | — | EP | claimed |
| WO-2013156228-A1 | METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT | FERRARA MARCELLO (IT) | 2013-10-24 | — | — | WO | claimed |
| US-20130270157-A1 | METHOD, APPARATUS AND CHEMICAL PRODUCTS FOR TREATING PETROLEUM EQUIPMENT | FERRARA MARCELLO (IT) | 2013-10-17 | — | — | US | claimed |
| US-20020002177-A1 | Endothelin receptor antagonists | SMITHKLINE BEECHAM CORPORATION | 2002-01-03 | — | — | US | claimed |
| JP-H08510211-A | — | — | 1996-10-29 | — | — | JP | claimed |
| EP-0699069-A4 | — | — | 1996-04-03 | — | — | EP | claimed |
| EP-0699069-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-03-06 | — | — | EP | claimed |
| WO-1995020637-A2 | HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS | MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) | 1995-08-03 | — | — | WO | claimed |
| WO-1994025013-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-11-10 | — | — | WO | claimed |
| JP-7300434-A | — | — | None | — | — | JP | disclosed |
| CN-113330078-B | Release layer and product containing release layer | 3M创新有限公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-113330078-A | Release layer and product containing release layer | 3M创新有限公司 | 2021-08-31 | — | — | CN | disclosed |
| CN-113122048-A | Ink composition and method of printing ink | 施乐公司 | 2021-07-16 | — | — | CN | disclosed |
| EP-0699069-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-03-06 | — | — | EP | disclosed |
| JP-H07300434-A | 2,3-DIPHENYLINDENE COMPOUND AND PHOTORECEPTOR FOR ELECTROPHOTOGRAPHY CONTAINING THE SAME COMPOUND | RICOH CO LTD | 1995-11-14 | — | — | JP | disclosed |
| WO-1995020637-A2 | HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS | MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) | 1995-08-03 | — | — | WO | disclosed |
| WO-1994025013-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-11-10 | — | — | WO | disclosed |
| US-4182915-A | PHENOL FROM BENZENE BY REACTION OF THALLIUM/III/ METALLATE WITH HYDROXYL DONOR | HALCON INTERNATIONAL, INC. (US) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002177-A1 | Endothelin receptor antagonists | EDNRA, EDNRB, ECE1 | CFTR 1621/4885GOPC 3560/4885LMNA 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.